What are the top 5 pharmaceutical companies?
The five biggest pharmaceutical companies by market cap are Johnson & Johnson, Novo Nordisk, Eli Lilly, AbbVie and Merck. The biggest pharmaceutical companies in the world are responsible for developing and manufacturing the vast majority of prescription drugs, giving them a key role in the life science industry.
- Pfizer. 2021 position: 1. Rx Sales: USD 72.043 billion. ...
- AbbVie. 2021 position: 3. Rx Sales: USD 55.041 billion. ...
- Novartis. 2021 position: 5. Rx Sales: USD 51.128 billion. ...
- J&J. 2021 position: 4. ...
- Roche. 2021 position: 2. ...
- BMS. 2021 position: 8. ...
- Merck & Co. (MSD) ...
- Sanofi. 2021 position: 10.
| # | Company | Growth ($m) |
|---|---|---|
| 1 | Pfizer Inc | -6505 |
| 2 | Novartis AG | -1193 |
| 3 | Merck & Co Inc | -688 |
| 4 | Sanofi | -1687 |
- Johnson & Johnson: $93.8 billion.
- Pfizer: $81.3 billion.
- Roche: $62.8 billion.
- AbbVie: $56.2 billion.
- Novartis: $52.9 billion.
- Merck: $48.7 billion.
- Bristol-Myers Squibb: $46.4 billion.
- Sanofi: $39.2 billion.
About 92 percent of prescription drugs in the United States are distributed through wholesalers, with three — AmerisourceBergen, Cardinal Health, and McKesson Corporation — accounting for more than 90 percent of wholesale drug distribution in the United States.
Who Is Pfizer's Largest Competitor? Johnson & Johnson is Pfizer's largest competitor. It might not generate as much revenue from its pharmaceuticals, but its market cap and total revenue make it a rival.
Johnson & Johnson Named a 2023 Fortune World's Most Admired Company and Ranked #1 on the Pharmaceutical Industry List Johnson & Johnson Named a 2023 Fortune World's Most Admired Company and Ranked #1 on the Pharmaceutical Industry List.
The top shareholders of Pfizer are Frank A. D'Amelio, Mikael Dolsten, Albert Bourla, Vanguard Group Inc., BlackRock Inc. (BLK), and State Street Corp. (STT).
The largest private pharma company in the world, Boehringer Ingelheim reported positive data from a recent trial of its treatment for GPP flares.
1) United States. It is well known that the US boasts a booming pharmaceutical business.
Which is the fastest growing company in pharmaceutical industry?
| Rank | Company | Revenue CAGR 5-Years |
|---|---|---|
| 1 | BioNTech | 319.0% |
| 2 | Moderna | 207.8% |
| 3 | Pfizer | 11.5% |
| 4 | Regeneron | 28.6% |
Pharmaceutical Drug, LIPITOR created, marketed, and sold by PFIZER corporation is regarded to be the most profitable drug in the pharma field. While it enjoyed patent protection, the drug generated over $131 billion in sales. Lipitor was released in 1997, the year which saw the FDA allow targeted drug ads.
Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr. Reddy's Laboratories Ltd, Torrent Pharmaceuticals Ltd, and Alkem Laboratories Ltd are the top 5 pharma companies in India by market capitalization (as of Sept 30, 2022).
The largest pharmaceutical company in the U.S. is Pfizer, with a revenue of $100.33 billion. As of 2021, the U.S. pharmaceutical industry has a market size of $560 billion.
- Novartis.
- Pfizer.
- Johnson & Johnson.
- Roche.
- Merck & Co.
- Moderna.
- BioNTech.
- AbbVie.
| Company Rank | Company Name | Country |
|---|---|---|
| 1 | Johnson & Johnson JNJ | USA |
| 2 | Roche RHHBY | Switzerland |
| 3 | Pfizer PFE | USA |
| 4 | Eli Lilly LLY | USA |
- Johnson & Johnson.
- Pfizer.
- Roche.
- AbbVie.
- Novartis.
- Merck.
- Bristol Myers Squibb.
- GlaxoSmithKline.
Johnson & Johnson is the leading Pharma company by market cap in the US (as of Mar 31, 2023). The company reported revenues of $94,943 million for the fiscal year ended January 2022 (FY2022), an increase of 1.2% over FY2021.
Who are the biggest big pharma?
The largest pharmaceutical company in the U.S. is Pfizer, with a revenue of $100.33 billion. As of 2021, the U.S. pharmaceutical industry has a market size of $560 billion. Over 4.76 billion retail prescriptions were filled in the U.S. in 2022.
| Rank | Company | Revenue CAGR 5-Years |
|---|---|---|
| 1 | BioNTech | 319.0% |
| 2 | Moderna | 207.8% |
| 3 | Pfizer | 11.5% |
| 4 | Regeneron | 28.6% |
- Sun Pharmaceutical Industries.
- Divi's Laboratories.
- Cipla.
- Dr. Reddy's Laboratories.
- Sun Pharma. Size: More than 10,000 employees. ...
- Pfizer. Size: More than 10,000 employees. ...
- Sanofi. Size: More than 10,000 employees. ...
- Novartis. Size: More than 10,000 employees. ...
- McKesson. Size: More than 10,000 employees. ...
- Johnson & Johnson. ...
- Takeda Pharmaceuticals. ...
- Roche.
| Rank | Company | 2020 Revenues ($USD) |
|---|---|---|
| Rank9 | CompanyPfizer | 2020 Revenues ($USD)$41,908,000,000 |
| Rank10 | CompanySanofi | 2020 Revenues ($USD)$41,086,740,000 |
| Rank11 | CompanyTakeda Pharmaceutical | 2020 Revenues ($USD)$29,948,845,895 |
| Rank12 | CompanyAstraZeneca | 2020 Revenues ($USD)$26,617,000,000 |
The pharma king of the world, India.
Entrenched pharma giants Pfizer, Merck & Co. and Johnson & Johnson may continue to hold the top spots as the biggest drugmakers by sales in 2023.
Several states, including Florida, Vermont, Colorado, Maine, New Mexico, and New Hampshire have enacted laws establishing importation programs for prescription drugs from Canada.
#1: Lipitor
Last but certainly not least, cholesterol-fighting drug Lipitor has generated a stunning $150.1 billion worth of business for Pfizer as of the end of 2017's third quarter. The figure is a well-secured sales record. The drug was approved in the United States in 1997, but almost wasn't.
- Keytruda. Evaluate estimated that Merck's PD-L1 inhibitor will add another $3 billion in new sales in 2023. ...
- Comirnaty. Pfizer and BioNTech's COVID-19 vaccine is expected to generate revenues under $ 20 billion in 2023. ...
- Humira. ...
- Paxlovid. ...
- Eliquis. ...
- Opdivo. ...
- Dupixent. ...
- Stelara.
